Though Tandem Diabetes has made a splash in the insulin pump market as the most recent entrant in the US, the firm is still endeavoring to establish itself as a major competitor. On this rather lengthy path between the initial 2012 launch of its original t:slim pump and consistent positive earnings from operations, Tandem still has a number of years to go, from our perspective.